FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including a 67.4% increase in the Rare Diseases portfolio, 9.2% ...

FY 2024 total sales growth of 9.9% at CER1, or 8.7% as reported, with growth driven by strong performance across all therapeutic areas, including a 67.4% increase in the Rare ...

SOUTH SAN FRANCISCO - Aligos Therapeutics, Inc. (NASDAQ:ALGS), a company specializing in therapies for liver and viral diseases with a current market capitalization of $96.58 million, announced today ...

Aligos Therapeutics (ALGS) has entered into a securities purchase agreement for a private placement that is expected to result in gross ...

Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical study Funding expected to extend cash runway into the second half of 2026 SOUTH SAN FRANCISCO, Calif., Feb. 12, 2025 (GLOBE ...

Check the time stamp on this data. Updated AI-Generated Signals for Aligos Therapeutics Inc. (ALGS) available here: ALGS.

Below is a month-by-month schedule of all the major esports events that will take place throughout the year 2025 ...

Apex Legends Season 24 brings several modifications including buffs for weapons, balance changes to existing legends, and a fresh battle pass for the first split. The community will be able to enjoy a ...

Apex Legends Season 24 features a plethora of weapon changes, all of which have been incorporated to shift the concrete gun ...

Game Designer John Larson discusses approaches to Legend and class changes, as well as how much of it is influenced by Apex Legends' esports league ...